Edition:
India

Clovis Oncology Inc (CLVS.OQ)

CLVS.OQ on NASDAQ Stock Exchange Global Select Market

24.84USD
1:30am IST
Change (% chg)

$-1.29 (-4.94%)
Prev Close
$26.13
Open
$26.05
Day's High
$26.30
Day's Low
$24.80
Volume
378,636
Avg. Vol
681,500
52-wk High
$65.17
52-wk Low
$11.50

Chart for

About

Clovis Oncology, Inc. is a biopharmaceutical company focused on acquiring, developing and commercializing anti-cancer agents in the United States, Europe and other international markets. The Company's product candidates include Rociletinib, Rubraca (Rucaparib) and Lucitanib. Rucaparib is an oral, small molecule poly adenosine... (more)

Overall

Beta: 1.61
Market Cap(Mil.): $4,124.93
Shares Outstanding(Mil.): 48.88
Dividend: --
Yield (%): --

Financials

Earnings vs. Estimates